Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
Isoyama K, Eguchi M, Hibi S, Kinukawa N, Ohkawa H, Kawasaki H, Kosaka Y, Oda T, Oda M, Okamura T, Nishimura S, Hayashi Y, Mori T, Imaizumi M, Mizutani S, Tsukimoto I, Kamada N, Ishii E.
Isoyama K, et al. Among authors: hayashi y.
Br J Haematol. 2002 Sep;118(4):999-1010. doi: 10.1046/j.1365-2141.2002.03754.x.
Br J Haematol. 2002.
PMID: 12199778
Free article.